2 Biotechs That Recently Soared -- Are They Buys?

The biotech industry is volatile. It's not that rare to see shares of relatively small drugmakers skyrocket on positive clinical or regulatory news. Case in point: Axsome Therapeutics (NASDAQ: AXSM) and DBV Technologies (NASDAQ: DBVT) -- two small-cap biotechs -- recently saw their shares explode following positive developments.

What exactly is going on with these companies? And are they worth buying today for investors focused on the long game? Here is the rundown on these two biotechs.

Continue reading

Source Fool.com